Hologic's Panther Fusion boosts growth with more than 20 approved assays and strong global adoption. BV, CV/TV test has become Hologic's second-largest assay, with large untapped U.S. testing ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Panther Fusion® ...

--New assays for the Panther Fusion and Novodiag Systems further build on Hologic’s leading molecular scalable solutions offering to European customers-- The Panther Fusion SARS-CoV-2/Flu A/B/RSV ...

Hologic gains FDA and CE approvals for its new Panther Fusion GI Bacterial and Expanded Assays. Hologic's new assays use rapid molecular tech to detect common bacterial causes of gastroenteritis.

Hologic, Inc. HOLX announced the receipt of the CE mark approval for two new molecular assays, Panther Fusion EBV Quant and Panther Fusion BKV Quant. The latest assay approvals expand the company’s ...

Molecular diagnostic tests newly launched in Europe by Hologic and Thermo Fisher each test for a handful of common respiratory viruses at once, including COVID-19, the flu, pneumonia and more.

Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...